Skip to main content

Vicarious Surgical Inc.

RBOT
Exchange
OTC
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001812173

No open-market purchases or sales by Vicarious Surgical Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $5.00K in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Vicarious Surgical Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of RBOT: Q1 2023 compared with Q2 2023
MeasureQ1 2023Of which not filed for Q2 2023Q2 2023Change
Holders79174−4
Shares46.2M33.2K47.6M+1.45M (+3.1%)
Value$101.9M$75.4K$86.1M−$15.7M (−15.4%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Vicarious Surgical Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to RBOT in Q2 2023
InstitutionSharesValue% of portfolio
Twin Focus Capital Partners, LLC80,000$146.4K0.03%
Dimensional Fund Advisors LP48,442$88.6K0.00%
Pathstone Family Office, LLC35,236$64.5K0.00%
McAdam, LLC22,901$41.9K0.00%
Price T Rowe Associates Inc12,650$24.0K0.00%
SRS Capital Advisors, Inc.12,905$23.6K0.00%
Citadel Advisors LLC1,046$1.91K0.00%
Northwestern Mutual Wealth Management Co500$9150.00%
Sound Income Strategies, LLC403$7370.00%
IFP Advisors, Inc35––

Sold out (14)

Institutions that held Vicarious Surgical Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Not filed for Q2 2023 yet (1)

Institutions that held Vicarious Surgical Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RBOT in Q1 2023 that haven't filed for Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Brainard Capital Management LLC33,236$75.4K